COVID-19 Rekindling Herpes Zoster in an Immunocompetent Patient

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2021 Oct 25

PMID 34692281

Citations 3

Authors

Piyush Puri

Pankul Parnami

Pal Satyajit Singh Athwal

Sima Kumari

Chandan Kumar

Yogita Suri

Affiliations

Soon will be listed here.

Abstract

During the coronavirus 2019 (COVID-19) pandemic, sundry dermatological conditions related to COVID-19 pneumonia have been published. COVID-19 primarily affects the respiratory system, but secondarily it also affects the heart, kidney, brain, skin, spinal cord, etc. Herpes Zoster (HZ) is considerably important morbidity associated with COVID-19 pneumonia. Recrudescence of HZ occurs because of the latent varicella-zoster virus (VZV) predominantly because of the decline in cell-mediated immunity (CMI). Abating CMI is due to the increasing age, but could also occur if the patient is suffering from an immunosuppressive disease or is using immunosuppressive drugs. In our case, the patient had no lymphopenia unlike the other cases, yet still, he developed HZ. HZ is associated with post-herpetic neuralgia (PHN), HZ ophthalmicus (HZO), and cerebral arteritis increasing morbidity and mortality, especially in elderly people and those who are immunocompromised.

Citing Articles

All available diagnostic and therapeutic options should be fully exploited in order to quickly identify and optimally treat neuropathic pain in long-COVID.

Finsterer J Eur Arch Psychiatry Clin Neurosci. 2024; 275(1):275-276.

PMID: 38695877 DOI: 10.1007/s00406-024-01820-0.

Progressive shingles in a toddler due to reactivation of Varicella Zoster vaccine virus four days after infection with SARS-CoV-2; a case report.

Miller C, Taylor-Salmon E, Emuren L, Landry M, Gershon A, Miller G BMC Infect Dis. 2023; 23(1):854.

PMID: 38057696 PMC: 10698951. DOI: 10.1186/s12879-023-08809-5.

Coronavirus disease 19 (COVID-19) and viral keratouveitis - unraveling the mystery.

Sanjay S, Kundu G, Deshpande V, Sethu S, Agrawal R, Ghosh A Indian J Ophthalmol. 2023; 71(8):3103-3108.

PMID: 37530289 PMC: 10538848. DOI: 10.4103/IJO.IJO_593_23.

References

Bostan E, Yalici-Armagan B . Herpes zoster following inactivated COVID-19 vaccine: A coexistence or coincidence?. J Cosmet Dermatol. 2021; 20(6):1566-1567. DOI: 10.1111/jocd.14035. View

Peitersen E . Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 2002; (549):4-30. View

Merad M, Martin J . Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020; 20(6):355-362. PMC: 7201395. DOI: 10.1038/s41577-020-0331-4. View

Cao X . COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020; 20(5):269-270. PMC: 7143200. DOI: 10.1038/s41577-020-0308-3. View

Eid E, Abdullah L, Kurban M, Abbas O . Herpes zoster emergence following mRNA COVID-19 vaccine. J Med Virol. 2021; 93(9):5231-5232. PMC: 8242521. DOI: 10.1002/jmv.27036. View

Maia C, Marques N, Lucena E, de Rezende L, Martelli D, Martelli-Junior H . Increased number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic. Int J Infect Dis. 2021; 104:732-733. PMC: 7877899. DOI: 10.1016/j.ijid.2021.02.033. View

Martinez E, Gatell J, Moran Y, Aznar E, Buira E, Guelar A . High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis. 1998; 27(6):1510-3. DOI: 10.1086/515019. View

Furer V, Zisman D, Kibari A, Rimar D, Paran Y, Elkayam O . Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Rheumatology (Oxford). 2021; 60(SI):SI90-SI95. PMC: 8083327. DOI: 10.1093/rheumatology/keab345. View

Bayas J, Gonzalez-Alvarez R, Guinovart C . Herpes zoster after yellow fever vaccination. J Travel Med. 2007; 14(1):65-6. DOI: 10.1111/j.1708-8305.2006.00098.x. View

10.

Polack F, Thomas S, Kitchin N, Absalon J, Gurtman A, Lockhart S . Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020; 383(27):2603-2615. PMC: 7745181. DOI: 10.1056/NEJMoa2034577. View

11.

Li H, Liu L, Zhang D, Xu J, Dai H, Tang N . SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020; 395(10235):1517-1520. PMC: 7164875. DOI: 10.1016/S0140-6736(20)30920-X. View

12.

Sweeney C, Gilden D . Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry. 2001; 71(2):149-54. PMC: 1737523. DOI: 10.1136/jnnp.71.2.149. View

13.

Sampathkumar P, Drage L, Martin D . Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009; 84(3):274-80. PMC: 2664599. DOI: 10.4065/84.3.274. View

14.

Wollina U, Karadag A, Rowland-Payne C, Chiriac A, Lotti T . Cutaneous signs in COVID-19 patients: A review. Dermatol Ther. 2020; 33(5):e13549. PMC: 7273098. DOI: 10.1111/dth.13549. View

15.

Pona A, Jiwani R, Afriyie F, Labbe J, Cook P, Mao Y . Herpes zoster as a potential complication of coronavirus disease 2019. Dermatol Ther. 2020; 33(6):e13930. PMC: 7361152. DOI: 10.1111/dth.13930. View

16.

Tartari F, Spadotto A, Zengarini C, Zanoni R, Guglielmo A, Adorno A . Herpes zoster in COVID-19-positive patients. Int J Dermatol. 2020; 59(8):1028-1029. PMC: 7307064. DOI: 10.1111/ijd.15001. View